Hepareg

Offcanvas

  • Home
  • About
    • About Hepareg
    • Plateforms and CHB
    • Legal notice
  • Projects and teams
    • 1- Modulation of cellular plasticity and liver bioengineering
    • 2- Bioconstruction of hepatic organoids
    • 3- Microbiota, Inflammation and Cancer
    • 4- Biliary homeostasis and hepatobiliary pathophysiology
  • Publications
    • Publications - Team 1
    • Publications - Team 2
    • Publications - Team 3
    • Publications - Team 4
      • Group 1
      • Group 2
      • Group 3
      • Group 4
  • News & events

Pathophysiology and Treatment of Liver Diseases

Linkedin
Intranet
  • French (fr-FR)
  • English (United Kingdom)
Hepareg
  • Home
  • About
    • About Hepareg
    • Plateforms and CHB
    • Legal notice
  • Projects and teams
    • 1- Modulation of cellular plasticity and liver bioengineering
    • 2- Bioconstruction of hepatic organoids
    • 3- Microbiota, Inflammation and Cancer
    • 4- Biliary homeostasis and hepatobiliary pathophysiology
  • Publications
    • Publications - Team 1
    • Publications - Team 2
    • Publications - Team 3
    • Publications - Team 4
      • Group 1
      • Group 2
      • Group 3
      • Group 4
  • News & events

Job offers

Publications - Team 1

Publications 2026

Publications 2026

Liver organoids: from promise to functional complexity.
Luce E, Duclos-Vallée JC.
Med Sci (Paris). 2026 Mar;42(3):270-279. doi: 10.1051/medsci/2026035. Epub 2026 Mar 20.PMID: 41860268 Review. French
In vitro space of Disse model for exploration of drug induced hepatoxicity.
Mesic A, Messina A, Tiprez Z, Charlot B, Ismail SM, Huang N, Bensalem S, Duclos-Vallee JC, Le Pioufle B.
Lab Chip. 2026 Apr 22;26(8):2577-2588. doi: 10.1039/d5lc01139f
The epigenetic regulator SETDB1 as a key component of cancer stem cells and drug resistance in primary liver cancer.
Padelli M, Desterke C, Devocelle A, Uzan G, Lemoine A, Giron-Michel J.
Cell Oncol (Dordr). 2026 Jan 6;49(1):18. doi: 10.1007/s13402-025-01157-3. PMID: 41493679; PMCID: PMC12775003.

Publications 2025

Publications 2025

Value of non-invasive test dynamics in guiding HCC surveillance decisions after HCV cure in patients with cirrhosis.
Nahon P, Lusivika-Nzinga C, Merle P, Zoulim F, Decaens T, Ganne-Carrié N, Pageaux GP, Leroy V, Alric L, Bronowicki JP, Bourlière M, Gournay J, Tran A, Pol S, Mathurin P, Loustaud-Ratti V, Métivier S, De Ledinghen V, Abergel A, Thabut D, D'Alteroche L, Bouattour M, Asselah T, Ouzan D, Cales P, Chazouillères O, Gelu-Simeon M, Roulot D, Boursier J, Cagnot C, Tamazirt S, Pascale A, Nilusmas S, Lewin M, Ziol M, Carrat F, Duclos-Vallée JC; ANRS CO12 CirVir, CO22 Hepather, and LICAVIR groups.
J Hepatol. 2025 Feb 26:S0168-8278(25)00084-4. Online ahead of print. PMID: 40020929 DOI: 10.1016/j.jhep.2025.02.00
State-of-the-Art Liver Cancer Organoids: Modeling Cancer Stem Cell Heterogeneity for Personalized Treatment.
Giron-Michel J, Padelli M, Oberlin E, Guenou H, Duclos-Vallée JC.
BioDrugs. 2025 Jan 18. Online ahead of print. doi: 10.1007/s40259-024-00702-0. PMID: 39826071.
Optimizing Detection of Circulating Tumor Cells in Breast Cancer: Unveiling New Markers for Clinical Applications.
Mehtar A, Wechsler J, Desterke C, Giron-Michel J, Bouzidi A, Burlion A, Louache F, Kahia-Tani S, Uzan G, Naserian S.
Int J Mol Sci. 2025 May 14;26(10):4714. doi: 10.3390/ijms26104714. PMID: 40429857; PMCID: PMC12111556.
Silence as a manner within the doctor’s epistemic posture during the diagnostic process. A case study in a French hospital.
Glauzy, A.
Social Science & Medicine. 2025 Aug:378:118153. PMID: 40339397 DOI: 10.1016/j.socscimed.2025.118153
The voice of sacrifice: The silence of healthcare professionals in service of productivity. The case of a French hospital.
Glauzy, A., Montlahuc-Vannod, A.
Social Science & Medicine. 2025 Jul:377:118110. PMID: 40319740 DOI: 10.1016/j.socscimed.2025.118110
Are All Alginate Dressings Equivalent?
Duciel L, Proust R, Ponsen AC, Ziarelli F, Coudreuse A, Jeanmichel L, Samardzic M, Uzan G, des Courtils C.
J Biomed Mater Res B Appl Biomater. 2025 Mar;113(3):e35557 doi: 10.1002/jbm.b.35557. PMID: 39976170.
The implications of the TNFα-TNFR2 immune checkpoint signaling pathway in cancer treatment: From immunoregulation to angiogenesis.
Emamalipour M, Shamdani S, Mansoori B, Uzan G, Naserian S.
Int J Cancer. 2025 Jan 1;156(1):7-19. doi: 10.1002/ijc.35130. Epub 2024 Aug 14. PMID: 39140321.
State-of-the-Art Liver Cancer Organoids: Modeling Cancer Stem Cell Heterogeneity for Personalized Treatment.
Giron-Michel J, Padelli M, Oberlin E, Guenou H, Duclos-Vallée JC.
BioDrugs. 2025 Mar;39(2):237-260. doi:10.1007/s40259-024-00702-0. Epub 2025 Jan 18. PMID: 39826071; PMCID: PMC11906529.
Optimizing Detection of Circulating Tumor Cells in Breast Cancer: Unveiling New Markers for Clinical Applications.
Mehtar A, Wechsler J, Desterke C, Giron-Michel J, Bouzidi A, Burlion A, Louache F, Kahia-Tani S, Uzan G, Naserian S.
Int J Mol Sci. 2025 May 14;26(10):4714. doi: 10.3390/ijms26104714. PMID: 40429857; PMCID: PMC12111556.

Publications 2024

Publications 2024

Autoimmune hepatitis recurrence after liver transplantation: "Les jeux sont faits".
Chouik Y, Corpechot C, Francoz C, De Martin E, Guillaud O, Abergel A, Altieri M, Barbier L, Besch C, Chazouillères O, Conti F, Dharancy S, Durand F, Duvoux C, Gugenheim J, Hardwigsen J, Hilleret MN, Houssel-Debry P, Kamar N, Minello A, Neau-Cransac M, Pageaux GP, Radenne S, Roux O, Saliba F, Samuel D, Vanlemmens C, Woehl-Jaegle ML, Leroy V, Duclos-Vallée JC, Dumortier J.
Liver Transpl. 2024 Apr 1;30(4):395-411. PMID: 37788303 DOI: 10.1097/LVT.0000000000000278
Exploring the impact of ursodeoxycholic acid therapy on COVID-19 in a real-word setting.
Corpechot C, Verdoux M, Frank-Soltysiak M, Duclos-Vallée JC, Grimaldi L.
J Med Virol. 2024 Jan;96(1):e29418. PMID: 38240338 DOI: 10.1002/jmv.29418
Community Versus Facility-Based Services to Improve the Screening of Active Hepatitis C Virus Infection in Cambodia: The ANRS 12384 CAM-C Cluster Randomized Controlled Trial-Protocol for a Mixed Methods Study.
Mosnier E, Ségéral O, Neth S, Sagaon-Teyssier L, Khuon D, Phoeung CL, Mam S, Chhay C, Heang K, Duclos-Vallée JC, Saphonn V.
JMIR Res Protoc. 2024 Nov 20;13:e63376. PMID: 39566053 PMCID: PMC11618004 DOI: 10.2196/63376
Regenerative and Anti-Senescence Potential of Extracts from Different Parts of Black Persimmon in an In Vitro Model of Vascular Endothelium.
Serio G, Naserian S, Fraj SB, Uzan G, Gentile C.
Foods. 2024 Oct 23;13(21):3366. doi: 10.3390/foods13213366. PMID: 39517149; PMCID: PMC11545823.
Fast and efficient isolation of murine circulating tumor cells using screencell technology for pre-clinical analyzes.
Ye F, Wechsler J, Bouzidi A, Uzan G, Naserian S.
Sci Rep. 2024 Jul 1;14(1):15019. doi: 10.1038/s41598-024-66032-x. PMID: 38951573; PMCID: PMC11217394.

Publications 2023

Publications 2023

Intrinsic cancer cell phosphoinositide 3-kinase δ regulates fibrosis and vascular development in cholangiocarcinoma.
Bou Malham V, Benzoubir N, Vaquero J, Desterke C, Agnetti J, Song PX, Gonzalez-Sanchez E, Arbelaiz A, Jacques S, Di Valentin E, Rahmouni S, Tan TZ, Samuel D, Thiery JP, Sebagh M, Fouassier L, Gassama-Diagne A.
Liver Int. 2023 Dec; 43(12):2776-2793. doi: 10.1111/liv.15751. Epub 2023 Oct 7. PMID: 37804055.
Le consentement médical à l’ère de la médecine de précision.
Glauzy, A., Baertschi, B., et Duclos-Vallée, J. C. (2023).
Médecine/Sciences, 39 (8-9) : 658-63. PMID: 37695156 DOI: 10.1051/medsci/2023093
Les enjeux du consentement dans la pratique médicale à l’ère de la médecine de précision.
Glauzy, A et Duclos-Vallée, J. C. (2023).
Nouvelle revue de psychosociologie, 35 (1) : 133-146.
 
Pathophysiology and Treatment of Liver Diseases

Pathophysiology and Treatment of Liver Diseases

About Hepareg Projects & Teams Publications Job offers
Legal Notice & Privacy Policy
Copyright © 2026 Hepareg. All Rights Reserved.
Réalisation : Agence de communication scientifique - radisnoir